Biogen is committed to helping people living with RMS. We can provide assistance once your patients are prescribed a Biogen treatment, such as TYSABRI. Biogen Support Services provides a variety of financial and insurance assistance options and other resources to help your patients get started on TYSABRI. We’re here to be a resource for your patients. And we’re just a phone call away at 1-800-456-2255.
When TYSABRI treatment cost may be a concern for your patients, Biogen is here to help them start and continue on TYSABRI.
We will work with your patients based on their individual needs. Biogen Support Services offers a variety of different financial and insurance resources to help manage the cost of TYSABRI, including:
aEffective January 1, 2021, there is an annual cap on the amount of assistance that patients can receive over a one-year period. Federal and state laws and other factors may prevent or otherwise restrict eligibility. People covered by Medicare, Medicaid, the VA/DoD, or any other federal plans are not eligible to enroll. You are eligible to enroll in the Biogen Copay Program for as long as it is offered and you are treated with a Biogen relapsing MS medication. The Biogen Copay Program is no longer available for TECFIDERA patients in the states of Massachusetts and California.
Biogen Case Managers (Support Coordinators) are here to help your patients start and continue on TYSABRI. A Biogen Case Manager will reach out to your patient after they are prescribed TYSABRI. Support is also available in Spanish.
Biogen Case Managers will also:
Biogen Nurse Educators are registered nurses. Many are MS-certified and are here for your patients who are prescribed TYSABRI. Biogen Nurse Educators are here to:
A Biogen Nurse Educator can come to your office and educate your staff on how they can help support your patients on TYSABRI. Biogen Nurse Educators can also provide patients with supplemental side-effect mitigation strategies and communicate with you about your patients’ start date and any treatment challenges they have expressed.